Manufacturer record
Aan Life science Private Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Aan Life science Private Limited (Gujarat) were declared Not of Standard Quality between June 2026 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
11 records linked to Aan Life science Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin Oral Suspension IP | PDB108AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB110AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB121AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB117AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB098AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB099AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB119AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB111AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB114AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB105AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
| Amoxycillin Oral Suspension IP | PDB107AMfg 2024-11 · Exp 2026-10 | Content of Amoxycillin.Other | FDL, VadodaraState lab | Jun 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.